PEDRO PABLO
ESPAÑA YANDIOLA
Investigador hasta 2024
Hospital Universitario de Basurto
Bilbao, EspañaPublicaciones en colaboración con investigadores/as de Hospital Universitario de Basurto (27)
2023
-
A second update on mapping the human genetic architecture of COVID-19
Nature
-
Erratum to: Mapping the human genetic architecture of COVID-19 (Nature, (2021), 600, 7889, (472-477), 10.1038/s41586-021-03767-x)
Nature
-
Impact of Prior SARS-CoV-2 Infection and Vaccination on COVID-19 Infection Among Nursing Home Residents
Journal of the American Medical Directors Association
-
Impact of prior SARS-COV-2 infection and vaccination on COVID-19 hospital admission and mortality amongst nursing home residents
Aging Clinical and Experimental Research, Vol. 35, Núm. 8, pp. 1771-1778
-
Persistent Respiratory Failure and Re-Admission in Patients with Chronic Obstructive Pulmonary Disease Following Hospitalization for COVID-19
International Journal of COPD, Vol. 18, pp. 2473-2481
-
Prior SARS-COV-2 infection, vaccination, COVID-19 hospital admission and mortality amongst nursing home residents: comment
Aging Clinical and Experimental Research
-
Residual pulmonary infiltrates, symptoms and diffusion impairment at 1-year after severe COVID-19 infection have different associated factors
Journal of Internal Medicine, Vol. 294, Núm. 1, pp. 69-82
2022
-
Author Correction: Machine learning-based model for prediction of clinical deterioration in hospitalized patients by COVID 19 (Scientific Reports, (2022), 12, 1, (7097), 10.1038/s41598-022-09771-z)
Scientific Reports
-
Detailed stratified GWAS analysis for severe COVID-19 in four European populations
Human Molecular Genetics, Vol. 31, Núm. 23, pp. 3945-3966
-
Utility of Differential White Cell Count and Cell Population Data for Ruling Out COVID-19 Infection in Patients With Community-Acquired Pneumonia
Archivos de Bronconeumologia, Vol. 58, Núm. 12, pp. 802-808
2021
-
Correction to: Impact of reducing the duration of antibiotic treatment on the long-term prognosis of community acquired pneumonia (BMC Pulmonary Medicine, (2020), 20, 1, (261), 10.1186/s12890-020-01293-6)
BMC Pulmonary Medicine
-
Mapping the human genetic architecture of COVID-19
Nature, Vol. 600, Núm. 7889, pp. 472-477
-
Predictors of mortality of COVID-19 in the general population and nursing homes
Internal and Emergency Medicine, Vol. 16, Núm. 6, pp. 1487-1496
2019
2017
2016
-
Duration of antibiotic treatment in community-acquired pneumonia: A multicenter randomized clinical trial
JAMA Internal Medicine, Vol. 176, Núm. 9, pp. 1257-1265
-
High Body Mass Index as a Risk Factor for Hospitalization Due to Influenza: A Case-Control Study
Archivos de Bronconeumologia, Vol. 52, Núm. 6, pp. 299-307
2015
-
Performance of pro-adrenomedullin for identifying adverse outcomes in community-acquired pneumonia
Journal of Infection, Vol. 70, Núm. 5, pp. 457-466
2014
-
Bacteremic pneumococcal pneumonia in elderly and very elderly patients
Journals of Gerontology - Series A Biological Sciences and Medical Sciences, Vol. 69, Núm. 8, pp. 1018-1024
-
Pneumococcal pneumonia: Differences according to blood culture results
BMC Pulmonary Medicine, Vol. 14, Núm. 1